BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23867551)

  • 1. Expression of cytochrome P450 2A5 in a C57BL/6J mouse model of nonalcoholic fatty liver disease.
    Li R; Guo G; Cao Y; Wang Y; Liu F; Zhang X
    Pharmacology; 2013; 92(1-2):26-31. PubMed ID: 23867551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarray analysis of hepatic gene expression in pyrazole-mediated hepatotoxicity: identification of potential stimuli of Cyp2a5 induction.
    Nichols KD; Kirby GM
    Biochem Pharmacol; 2008 Jan; 75(2):538-51. PubMed ID: 17945193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoplasmic reticulum stress due to altered cellular redox status positively regulates murine hepatic CYP2A5 expression.
    Gilmore WJ; Kirby GM
    J Pharmacol Exp Ther; 2004 Feb; 308(2):600-8. PubMed ID: 14610226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cytochrome P450 2A5 in a glucose-6-phosphate dehydrogenase-deficient mouse model of oxidative stress.
    Nichols KD; Kirby GM
    Biochem Pharmacol; 2008 Mar; 75(5):1230-9. PubMed ID: 18068688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation.
    Cui Y; Wang Q; Li X; Zhang X
    Redox Biol; 2013; 1(1):433-40. PubMed ID: 24191237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 2A5 and bilirubin: mechanisms of gene regulation and cytoprotection.
    Kim SD; Antenos M; Squires EJ; Kirby GM
    Toxicol Appl Pharmacol; 2013 Jul; 270(2):129-38. PubMed ID: 23628428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lipopolysaccharide-stimulated inflammation and pyrazole-mediated hepatocellular injury on mouse hepatic Cyp2a5 expression.
    Gilmore WJ; Hartmann G; Piquette-Miller M; Marriott J; Kirby GM
    Toxicology; 2003 Mar; 184(2-3):211-26. PubMed ID: 12499123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential xenobiotic induction of CYP2A5 in mouse liver, kidney, lung, and olfactory mucosa.
    Su T; He W; Gu J; Lipinskas TW; Ding X
    Drug Metab Dispos; 1998 Aug; 26(8):822-4. PubMed ID: 9698299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Fatty Acids on CYP2A5 and Nrf2 Expression in Mouse Primary Hepatocytes.
    Cui Y; Wang Q; Yi X; Zhang X
    Biochem Genet; 2016 Feb; 54(1):29-40. PubMed ID: 26423681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cytochrome P450 2A5 in preneoplastic and neoplastic mouse liver lesions.
    Wastl UM; Rossmanith W; Lang MA; Camus-Randon AM; Grasl-Kraupp B; Bursch W; Schulte-Hermann R
    Mol Carcinog; 1998 Aug; 22(4):229-34. PubMed ID: 9726815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrazole-inducible proteins in DBA/2 mouse liver bind with high affinity to the 3'-untranslated regions of the mRNAs of coumarin hydroxylase (CYP2A5) and c-jun.
    Thulke-Gross M; Hergenhahn M; Tilloy-Ellul A; Lang M; Bartsch H
    Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):473-81. PubMed ID: 9531487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heme and heme biosynthesis intermediates induce heme oxygenase-1 and cytochrome P450 2A5, enzymes with putative sequential roles in heme and bilirubin metabolism: different requirement for transcription factor nuclear factor erythroid- derived 2-like 2.
    Lämsä V; Levonen AL; Sormunen R; Yamamoto M; Hakkola J
    Toxicol Sci; 2012 Nov; 130(1):132-44. PubMed ID: 22859313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5.
    Abu-Bakar A; Moore MR; Lang MA
    Biochem Pharmacol; 2005 Nov; 70(10):1527-35. PubMed ID: 16183037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute cadmium chloride administration induces hepatic and renal CYP2A5 mRNA, protein and activity in the mouse: involvement of transcription factor NRF2.
    Abu-Bakar A; Satarug S; Marks GC; Lang MA; Moore MR
    Toxicol Lett; 2004 Mar; 148(3):199-210. PubMed ID: 15041070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Induction of cytochrome P450 2A5 in transplanted mouse hepatoma].
    Kulikova LN
    Biomed Khim; 2004; 50(3):260-8. PubMed ID: 15354536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of CYP2A5 expression by porphyrinogenic agents in mouse liver.
    Salonpää P; Krause K; Pelkonen O; Raunio H
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):446-52. PubMed ID: 7543189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement by pyrazole of lipopolysaccharide-induced liver injury in mice: role of cytochrome P450 2E1 and 2A5.
    Lu Y; Cederbaum AI
    Hepatology; 2006 Jul; 44(1):263-74. PubMed ID: 16799984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function and regulation of the Cyp2a5/CYP2A6 genes in response to toxic insults in the liver.
    Abu-Bakar A; Hakkola J; Juvonen R; Rahnasto-Rilla M; Raunio H; Lang MA
    Curr Drug Metab; 2013 Jan; 14(1):137-50. PubMed ID: 22497566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of CYP2A5 by pyrazole and its derivatives in mouse primary hepatocytes.
    Kojo A; Viitala P; Pasanen M; Pelkonen O; Raunio H; Juvonen R
    Arch Toxicol; 1998 May; 72(6):336-41. PubMed ID: 9657280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coactivator PGC-1alpha regulates the fasting inducible xenobiotic-metabolizing enzyme CYP2A5 in mouse primary hepatocytes.
    Arpiainen S; Järvenpää SM; Manninen A; Viitala P; Lang MA; Pelkonen O; Hakkola J
    Toxicol Appl Pharmacol; 2008 Oct; 232(1):135-41. PubMed ID: 18602936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.